Drug intelligence / Profile preview

oxytetracycline + dexamethasone

Development stage
Unknown
Lead developer
Wayzon Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Delta Oxy Bolus is a veterinary combination medication developed by Wayzon Pharma, containing the broad-spectrum antibiotic oxytetracycline and the synthetic corticosteroid dexamethasone. Oxytetracycline exerts its antibacterial effect by binding to the 30S ribosomal subunit of susceptible bacteria, thereby inhibiting protein synthesis. It is active against a wide range of Gram-positive and Gram-negative bacteria, as well as Rickettsia and Mycoplasma. Dexamethasone provides potent anti-inflammatory and anti-stress activity by acting as an agonist at the glucocorticoid receptor. This combination is specifically formulated for livestock to treat systemic and local infections, such as pneumonia, metritis, and hemorrhagic septicemia, where the reduction of associated inflammation and toxemia is clinically beneficial for recovery.

Brand names
Delta Oxy Bolus
Other names
Delta-Oxy Bolus
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on oxytetracycline + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxytetracycline + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call